Results of a 1-year quality-improvement process to reduce door-to-needle time in acute ischemic stroke with MRI screening

Autor: Julie Mas, Bénédicte Fadat, C. Heroum, Denis Sablot, P. Perucho, C. Gely, C. Pujol, Y. Garcia, Stephane Bouly, Nicolas Gaillard, A. Laverdure, H. Touzani, C. Sagnes-Raffy, S. Jurici, J.-M. Bonnec, A. Dutray, G. Farouil, C. Richard, A. Dumitrana, P. Smadja, C. Colas, Thierry Moulin, D. Heve, M. Jantac, T. Allou, Nadège Olivier, A. Ferraro-Allou

Publikováno v: Revue neurologique. 173(1-2)

To determine the effects of a 1-year quality-improvement (QI) process to reduce door-to-needle (DTN) time in a secondary general hospital in which multimodal MRI screening is used before tissue plasminogen activator (tPA) administration in patients w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6c0eb0ed6480f5e495c9b184972db2a
https://pubmed.ncbi.nlm.nih.gov/28131535

Introduction

Autor: J. Bousquet, R. Bourret, T. Camuzat, P. Augé, P. Domy, J. Bringer, N. Best, O. Jonquet, J.-E. de la Coussaye, M. Noguès, J.-M. Robine, A. Avignon, H. Blain, B. Combe, G. Dray, V. Dufour, M. Fouletier, N. Giraudeau, D. Hève, C. Jeandel, I. Laffont, D. Larrey, D. Laune, C. Laurent, P. Mares, C. Marion, E. Pastor, J.-Y. Pélissier, F. Radier-Pontal, J. Reynes, E. Royère, M. Ychou, A. Bedbrook, S. Granier, F. Abecassis, S. Albert, P.-A. Adnet, B. Alomène, M. Amouyal, S. Arnavielhe, T. Asteriou, V. Attalin, P. Aubas, C. Azevedo, M. Badin, null Bakhti, G. Baptista, B. Bardy, M.-P. Battesti, O. Bénézet, P.-L. Bernard, C. Berr, J. Berthe, X. Bobia, J. Bockaert, C. Boegner, S. Boichot, H.-Y. Bonnin, P. Boulet, S. Bouly, C. Boubakri, A. Bourdin, J.-L. Bourrain, G. Bourrel, V. Bouix, C. Breuker, V. Bruguière, J. Burille, S. Cade, D. Caimmi, M.-V. Calmels, W. Camu, G. Canovas, V. Carre, G. Cavalli, G. Cayla, R. Chiron, P.-G. Claret, P. Coignard, F. Coroian, D.-J. Costa, P. Costa, null Cottalorda, B. Coulet, A.-L. Coupet, M.-C. Courrouy-Michel, P. Courtet, J.-P. Cristol, V. Cros, F. Cuisinier, C. Daien, M. Danko, P. Dauenhauer, M. Dauzat, M. David, J.-M. Davy, D. Delignières, P. Demoly, J. Desplan, H. Dhivert-Donnadieu, P. Dujols, A. Dupeyron, G. Dupeyron, O. Engberink, M. Enjalbert, C. Fattal, J. Fernandes, P. Fesler, P. Fraisse, J. Froger, P. Gabrion, E. Galano, M. Gellerat-Rogier, A. Gellis, A.-Y. Goucham, F. Gouzi, F. Gressard, J.-C. Gris, B. Guillot, D. Guiraud, V. Handweiler, H. Hantkié, M. Hayot, C. Hérisson, C. Heroum, D. Hoa, S. Jacquemin, S. Jaber, D. Jakovenko, C. Jorgensen, L. Journot, M. Kaczorek, P. Kouyoudjian, P. Labauge, L. Landreau, M. Lapierre, C. Leblond, M.-S. Léglise, J.-M. Lemaitre, V. Le Moing, A. Le Quellec, F. Leclercq, S. Lehmann, B. Lognos, J.-M. Lussert, A. Makinson, K. Mandrick, V. Marmelat, P. Martin-Gousset, A. Matheron, G. Mathieu, M. Meissonnier, G. Mercier, P. Messner, C. Meunier, M. Mondain, R. Morales, J. Morel, D. Morquin, D. Mottet, P. Nérin, P. Nicolas, G. Ninot, F. Nouvel, J.-P. Ortiz, D. Paccard, G. Pandraud, M.-P. Pasdelou, J.-L. Pasquié, K. Patte, S. Perrey, Y.-M. Pers, M.-C. Picot, J.-P. Pin, N. Pinto, E. Porte, F. Portejoie, J.-L. Pujol, X. Quantin, I. Quéré, N. Raffort, S. Ramdani, J. Ribstein, I. Rédini-Martinez, S. Richard, K. Ritchie, J.-P. Riso, F. Rivier, C. Rolland, F. Roubille, D. Sablot, J.-L. Savy, L. Schifano, P. Senesse, R. Sicard, B. Soua, Y. Stephan, D. Strubel, A. Sultan, null Taddei-Ologeanu, G. Tallon, M. Tanfin, H. Tassery, I. Tavares, K. Torre, J. Touchon, V. Tribout, A. Uziel, P. Van de Perre, X. Vasquez, J.-M. Verdier, C. Vergne-Richard, G. Vergotte, L. Vian, C. Viarouge-Reunier, F. Vialla, F. Viart, M. Villain, M. Villiet, E. Viollet, A. Wojtusciszyn, M. Aoustin, C. Bourquin, J. Mercier

Publikováno v: La Presse Médicale
La Presse Médicale, 2015, 44, ⟨10.1016/j.lpm.2015.07.014⟩
La Presse Médicale, Elsevier Masson, 2015, 44, ⟨10.1016/j.lpm.2015.07.014⟩

International audience

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e61cf3477ed01d9793fbc309d6916b95
https://hal.umontpellier.fr/hal-02565513

Une cause rare d’embolie cérébrale : la cardiopathie amyloïde

Autor: F. De Graeve, M. Pagès, A. Lequellec, A. Saux, C. Sportouch, C. Heroum

Publikováno v: Revue Neurologique. 162:1128-1130

Resume Introduction Nous rapportons un cas de cardiopathie amyloide revele par une embolie cerebrale. Observation Une patiente de 55 ans fut hospitalisee pour une hemiplegie droite avec aphasie par occlusion sylvienne gauche. L’echocardiographie fi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0f5f2afc68eb6ca3dbc178bd67f1fb39
https://doi.org/10.1016/s0035-3787(06)75127-x

[Amyloid cardiomyopathy: A rare cause of cerebral embolism]

Autor: A, Saux, C, Heroum, C, Sportouch, F, De Graeve, A, Lequellec, M, Pagès

Publikováno v: Revue neurologique. 162(11)

We report a case of amyloid cardiopathy revealed by a cerebral embolism.A 55-year-old patient was admitted with a right hemiplegia and aphasia due to an infarction in the middle cerebral artery territory. Echocardiography was suggestive of an amyloid

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::dfb4ae70a0fa7941c123111a607aa468
https://pubmed.ncbi.nlm.nih.gov/17086151

[Hypokalaemic paralysis as a presentation of adrenal tumor]

Autor: C, Briere, D, Milhaud, C, Heroum, I, Ringeard, J-M, Blard, M, Pagès

Publikováno v: Revue neurologique. 159(12)

A 24-year-old patient presented with flaccid quadriplegia due to severe hypokaliemia, initially presumed to have been induced by glycyrrhizin. Persistence of low potassium levels and hypertension led to the diagnosis of primary hyperaldosteronism rel

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7cb879d95562bee0aac823acae18542e
https://pubmed.ncbi.nlm.nih.gov/14978420